|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 产碳青霉烯酶肠杆菌科细菌快速碳青霉烯灭活试验的评价显示文摘碳青霉烯类耐药肠杆菌科细菌(CRE)所致感染病例在全球范围内日益增多,导致病死率高,并增加医疗费用。产生碳青霉烯酶是CRE最主要的耐药机制,导致对其所致感染的治疗药物极其有限。此外,碳青霉烯酶基因往往存在于可移动元件或质粒上,能在不同细菌间水平传播。为控制该类耐药菌的流行播散,实验室需要建立一种快速可靠、低成本检测菌株中碳青霉烯酶的方法。 | 韩仁如 胡付品 Muntean MM Muntean AA Gauthier L | 2018 | 中国感染与化疗杂志2018，18，5： | 4 |
| 2 | Type 3(CaO·Al2O3)·Mx(SO4)y compounds and compatibility reactions in CaO-CaO·Al2O3-Mx(SO4)y system显示文摘 | TEOREANU I MUNTEAN M DRAGNEA I | 1986 | Il Cemento1986，83，1： | 3 |
| 3 | Multimodality treatment strategies have changed prognosis of peritoneal metastases显示文摘For a long time, treatment of peritoneal metastases(PM) was mostly palliative and thus, this status was link with 'terminal status/despair'. The current multimodal treatment strategy, consisting of cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC), has been strenuously achieved over time, but seems to be the best treatment option for PM patients. As we reviewed the literature data, we could emphasize some milestones and also, controversies in the history of proposed multimodal treatment and thus, outline the philosophy of this approach, which seems to be an unusual one indeed. Initially marked by nihilism and fear, but benefiting from a remarkable joint effort of human and material resources(multi-center and-institutional research), over a period of 30 years, CRS and HIPEC found their place in the treatment of PM. The next 4 years were dedicated to the refinement of the multimodal treatment, by launching research pathways. In selected patients, with requires training, it demonstrated a significant survival results(similar to the Hepatic Metastases treatment), with acceptable risks and costs. The main debates regarding CRS and HIPEC treatment were based on the oncologists' perspective and the small number of randomized clinical trials. It is important to statement the PM patient has the right to be informed of the existence of CRS and HIPEC, as a real treatment resource, the decision being made by multidisciplinary teams. | corneliu lungoci aurel ion mironiuc valentin muntean traian oniu hubert leebmann max mayr pompiliu piso | 2016 | World Journal of Gastrointestinal Oncology2016，8，1： | 2 |
| 4 | Road vehicle emission factors development: A review显示文摘 | Vicente Franco Marina Kousoulidou Marilena Muntean Leonidas Ntziachristos Stefan Hausberger Panagiota Dilara | 2013 | Atmospheric Environment2013，，： | 2 |
| 5 | Fresh frozen plasma in the pediatric age group and in congenital coagulation factor deficiency显示文摘 | Muntean W | 2002 | Thromb Res2002，107，1： | 1 |
| 6 | Flow cytometric detection of intracellular platelets antigens 显示文摘 | Sedmayr P Grobhaupt B Muntean W | 1996 | Cytometry1996，23，4： | 1 |
| 7 | Magmatic--hydrothermal origin of Ne- vada~ s Carlin- type gold deposits显示文摘 | Muntean J L J S Cline A C Simon | 2011 | Nature Geoscience2011，4，12： | 1 |
| 8 | Pharmacokinetics and compar ative bioavailability of two fenofibrate capsule formulations in healthy volunteers显示文摘 | Vlase L Popa A Muntean D | 2010 | Arzneimittelforschung2010，60，9： | 1 |
| 9 | Staging laparoscopy in digestive cancers显示文摘 | Muntean V Oniu T Lungoci C | 2009 | J Gastrointestin Liver Dis2009，18，4： | 1 |
| 10 | Optimizing longcirculating liposomes for delivery of simvastatin to C26colon carcinoma cells显示文摘 | Porfire A Tomuta I Muntean D | 2014 | J Liposome Res2014，9，： | 1 |
| 11 | Additive effects of anticoagulants: recombinant human activated protein C and heparin or mdagatran, in tissue factor-activated umbilical-cord plasma 显示文摘 | Koestenberger M Gallistl S Muntean W | 2005 | Thromb-Haemoat2005，94，1： | 1 |
| 12 | Determination of lorutu- dine and its active metabolite in human plasma by high-perform- ance liquid chromatography with mass spectrometry detection 显示文摘 | VLASE L IMRE S MUNTEAN D | 2007 | J Pharm Biomed Anal2007，44，3： | 1 |
| 13 | Magmatic–hydrothermal origin of Nevada’s Carlin-type gold deposits显示文摘 | Muntean J L Cline J S Simon A C | 2011 | Nature Geoscience2011，4，： | 1 |
| 14 | Desflurane-induced Preconditioning Alters Calcium-induced Mitochondrial Permeability Transition显示文摘 | Vincent Piriou Pascal Chiari Odile Gateau-Roesch Laurent Argaud Danina Muntean Delphine Salles Joseph Loufouat Pierre-Yves Gueugniaud Jean-Jacques Lehot Michel Ovize | 2004 | Anesthesiology2004，，3： | 1 |
| 15 | Adaptive energyoptimization in multimedia-centric wireless devices: asurvey显示文摘 | Ksentini A Hadijadj A Y Muntean G M | 2012 | IEEE Communications Surveys & Tutorials2012，，99： | 1 |
| 16 | CYR61 (CCN1) is essential for placental development and vascular integrity 显示文摘 | Mo FE Muntean AG Chen CC | 2002 | Mol Cell Biol2002，22，24： | 1 |
| 17 | Flow cytometric detection of intracellular platelet antigens显示文摘 | Sedlmayr P Grobhaupt B Muntean W | 1996 | Cytometry1996，23，： | 1 |
| 18 | Staging laparoscopy in gastric cancer, accuracy and impact on therapy显示文摘 | Muntean V Mihailov A Iancu C | 2009 | J Gastrointestin Liver Dis2009，18，2： | 1 |
| 19 | Short-Term Intravenous Fish-Oil Emulsions in Pediatric Oncologic Patients—Effect on Liver Parameters显示文摘 | K. Martin Hoffmann Michael Grabowski Siegfried R?dl Andrea Deutschmann Gerold Schwantzer Petra Sovinz Volker Strenger Christian Urban Wolfgang Muntean Almuth C. Hauer | 2014 | Nutrition and Cancer2014，，6： | 1 |
| 20 | Staging laparoscopy in digestive cancers 显示文摘 | Muntean V Oniu T Lungoei C | 2009 | J Gaslrointestin Liver Dis2009，18，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员